Background:
Upper limb dysfunction is one of the common and important functional disorders in ictus patients. Upper limb dysfunction is often more difficult to recover than lower limb dysfunction, and it can also have a negative impact on lower limb función Therefore, the rehabilitación of upper limb dysfunction in ictus patients has always been regarded as the focus and difficulty of clinical rehabilitación.
Mirror terapia (MT) is a mano función rehabilitación training method. The doctor asks the paciente to place the healthy mano outside the mirror box and the affected mano inside the mirror box. When the healthy mano moves, the paciente is asked to observe the mirror image in the mirror, so that the paciente has an illusion that the affected mano is moving. The purpose of this tratamiento method is to stimulate the paciente's brain to observe, imagine and imitate movements through visual feedback, so as to implement rehabilitación training. The theoretical basis of MT is the mirror neuron theory. The theory holds that when observing the behavior of others, certain neurons in the observer's brain will be activated, as if the observer is also performing the same action. This phenomenon suggests that the brain has a certain plasticity and can change its structure and función through visual feedback to achieve the purpose of rehabilitación. At present, MT has been widely used in the rehabilitación of upper limb dysfunction in ictus patients. Many studies have shown that MT has a good effect in improving upper limb motor función and daily living activities in ictus patients. With the development of science and technology, especially the advancement of intelligent rehabilitación technology, more and more MT based on intelligent rehabilitación equipment have sprung up, which undoubtedly opens up more new possibilities for the development of MT. This study compared the rehabilitación effects of innovative MT and traditional MT on upper limb dysfunction in ictus patients.

Figure 1 Innovative MT(Syrebo Mano Rehabilitación Robot SY-HR08E) and traditional MT mano función training diagram
Objective
To evaluate the rehabilitación effect of innovative mirror terapia (MT) on the upper limb función and daily living activity ability of ictus patients.
Methods
Sixty patients with impaired mano función after ictus were enrolled and divided into the intervention (n = 30) and control groups (n = 30) according to the random number table method. Patients in the intervention group received conventional rehabilitación training combined with innovative MT, and those in the control group received conventional rehabilitación training and conventional MT. Before tratamiento and 4 weeks after tratamiento, the Fugl-Meyer Assessment Scale for the upper limb (FMA-UE), the Fugl-Meyer Assessment Scale for the wrist and fingers (FMA-WH), and the modified Barthel Index (MBI) were evaluated to compare the rehabilitación effects between two groups.
Results
After 4 weeks of tratamiento, the FMA-UE, FMA-WH, and MBI scores of patients in two groups were higher than those before tratamiento (all P < 0.05). The FMA-UE, FMA-WH, and MBI scores in the intervention group were higher than those in the control group (50.00 (25.75, 57.25) vs.24.00 (9.75, 51.50), 12.00(1.75, 14.75) vs. 0(0, 12.50), 24.50(13.00, 28.75) vs.13.00(4.75, 21.00), all P < 0.05). The differences before and after tratamiento of FMA-UE, FMA-WH and MBI scores in the intervention group were all higher than those in the control group (all P < 0.05).



Conclusion
Compared with traditional MT, innovative MT(Syrebo Mano Rehabilitación Robot SY-HR08E) yields higher efficacy in improving upper limb función and enhancing the daily living capability of patients with impaired mano función after ictus. As a new rehabilitación tratamiento technology, innovative MT has high clinical application value for mano dysfunction caused by neurological diseases.
Reference: CHEN Tao , LIU Shaxin , CHEN Xuelian , MAO Lei , LI Debo , GAN Linyu. Rehabilitación effect of innovative mirror terapia on upper limb impairment in ictus patients[J]. JOURNAL OF NEW MEDICINE, 2024, 55(6): 397-402 https://doi.org/10.3969/j.issn.0253-9802.2024.06.001